These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35383308)

  • 1. Expanding the spectrum of cancer targets by predicting individual gene fusions.
    Nat Biotechnol; 2022 Aug; 40(8):1188-1189. PubMed ID: 35383308
    [No Abstract]   [Full Text] [Related]  

  • 2. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering and understanding oncogenic gene fusions through data intensive computational approaches.
    Latysheva NS; Babu MM
    Nucleic Acids Res; 2016 Jun; 44(10):4487-503. PubMed ID: 27105842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TumorFusions: an integrative resource for cancer-associated transcript fusions.
    Hu X; Wang Q; Tang M; Barthel F; Amin S; Yoshihara K; Lang FM; Martinez-Ledesma E; Lee SH; Zheng S; Verhaak RGW
    Nucleic Acids Res; 2018 Jan; 46(D1):D1144-D1149. PubMed ID: 29099951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent gene fusions in prostate cancer: their clinical implications and uses.
    Hessels D; Schalken JA
    Curr Urol Rep; 2013 Jun; 14(3):214-22. PubMed ID: 23625457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying patients with NTRK fusion cancer.
    Solomon JP; Benayed R; Hechtman JF; Ladanyi M
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Trombetta D; Sparaneo A; Muscarella LA
    Future Oncol; 2021 Feb; 17(5):487-490. PubMed ID: 33399024
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical algorithms improve accuracy of gene fusion detection.
    Hsieh G; Bierman R; Szabo L; Lee AG; Freeman DE; Watson N; Sweet-Cordero EA; Salzman J
    Nucleic Acids Res; 2017 Jul; 45(13):e126. PubMed ID: 28541529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression.
    Powers MP
    Oncogene; 2019 Nov; 38(47):7197-7199. PubMed ID: 31616060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].
    Schmidt F; Scheble V; Mertz K; Perner S; Rubin MA
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1483-6. PubMed ID: 19572250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
    Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS
    Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate and efficient detection of gene fusions from RNA sequencing data.
    Uhrig S; Ellermann J; Walther T; Burkhardt P; Fröhlich M; Hutter B; Toprak UH; Neumann O; Stenzinger A; Scholl C; Fröhling S; Brors B
    Genome Res; 2021 Mar; 31(3):448-460. PubMed ID: 33441414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of TRK fusion cancer.
    Kummar S; Italiano A; Brose MS; Carlson JJ; Sullivan SD; Lassen U; Federman N
    Am J Manag Care; 2022 Jan; 28(2 Suppl):S15-S25. PubMed ID: 35201680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of recurrent gene fusions in common epithelial tumors.
    Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
    Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
    Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
    Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.